Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease

This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.